Specific MR Contrast Media for Liver Imaging

作者: F Terrier , JP Vallée , S Pochon , N Howarth , CD Becker

DOI: 10.1007/978-3-642-58641-5_29

关键词:

摘要: The two major goals of magnetic resonance imaging (MRI) the liver are cancer detection and tissue characterization. However, in this respect, MRI has a strong competitor, namely computed tomography (CT). Indeed, with advent spiral technique better understanding pharmacokinetics iodinated contrast media, highly optimized CT protocols, such as double-phase CT, have been established clinical practice. This resulted greatly improved imaging. Focal le-sions less than 1 cm now routinely detected (Hollett et al. 1995). although sensitivity detecting focal lesions is first requisite an procedure, characterization small also great importance, because high prevalence (>20%) benign hepatic tumors, particularly hemangiomas, general adult population (Karhunen 1986). Unfortunately, often difficult (Hanafusa Even common cysts, when 10 mm size, can be troublesome. In fact, we encounter same problems those already facing chest CT. Thanks to exquisite resolution obtained lung parenchyma, peripheral nodules, few frequently detected. given patient, it impossible decide certainty whether they represent lesions, granulomas, or malignant metastases. concern, patient known malignancy, presence absence metastases may crucial choice appropriate therapy. One further aspect consider that percutaneous biopsy these liver, low yield for cytologic histologic diagnosis.

参考文章(98)
Fenton Schaffner, Hans Popper, Progress in Liver Diseases ,(1982)
Herbert Y. Kressel, Magnetic resonance annual Raven Press. ,(1985)
Paul H Brown, Jack E Juni, David A Lieberman, Gerbail T Krishnamurthy, None, Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. The Journal of Nuclear Medicine. ,vol. 29, pp. 623- 630 ,(1988)
G Schuhmann-Giampieri, H Schmitt-Willich, W R Press, C Negishi, H J Weinmann, U Speck, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. ,vol. 183, pp. 59- 64 ,(1992) , 10.1148/RADIOLOGY.183.1.1549695
William C. Small, Rendon C. Nelson, Gillian M. Sherbourne, Michael E. Bernardino, Enhancement effects of a hepatocyte receptor-specific MR contrast agent in an animal model. Journal of Magnetic Resonance Imaging. ,vol. 4, pp. 325- 330 ,(1994) , 10.1002/JMRI.1880040317
MANRITA K. SIDHU, HOLDE H. MULLER, JUDITH AGGELER, ALBERT L. JONES, STUART W. YOUNG, Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function. Investigative Radiology. ,vol. 28, pp. 903- 910 ,(1993) , 10.1097/00004424-199310000-00007
G. W. Kabalka, M. A. Davis, T. H. Moss, E. Buonocore, K. Hubner, E. Holmberg, K. Maruyama, L. Huang, Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liver Magnetic Resonance in Medicine. ,vol. 19, pp. 406- 415 ,(1991) , 10.1002/MRM.1910190231
Klaus P. Aicher, Michael Laniado, Andreas F. Kopp, Eckart Grönewäller, Stephan H. Duda, Claus D. Claussen, Mn‐DPDP–enhanced MR imaging of malignant liver lesions: Efficacy and safety in 20 patients Journal of Magnetic Resonance Imaging. ,vol. 3, pp. 731- 737 ,(1993) , 10.1002/JMRI.1880030507
G Elizondo, R Weissleder, D D Stark, J Guerra, J Garza, C J Fretz, L E Todd, J T Ferrucci, Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology. ,vol. 174, pp. 797- 801 ,(1990) , 10.1148/RADIOLOGY.174.3.2305063